Glycobiology/Glycomics Market - Global Industry Analysis

Glycobiology/Glycomics Market By Product (Enzymes, Instrument, Carbohydrates, Kits, Reagents and Chemicals, Others), By Application (Disease Diagnostics, Drug Discovery & Development, Others), By End User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Academic Research Institutes), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 19-Aug-2022 Category: Biotechnology Report Format : PDF Pages: 247 Report Code: ZMR-4939 Status : Published

The global glycobiology/glycomics market size was worth USD 962.40 million in 2021 and is estimated to grow to USD 2157.30 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.40 percent over the forecast period.

Description

Glycobiology/Glycomics Market Size And Industry Analysis

The global glycobiology/glycomics market size was worth USD 962.40 million in 2021 and is estimated to grow to USD 2157.30 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.40 percent over the forecast period. The report analyzes the glycobiology/glycomics market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the glycobiology/glycomics market.

Glycobiology/Glycomics Market: Overview

Glycomics, also known as glycobiology, studies the structure and function of saccharides found in nature and classified as glycans. Glycan can be found in a variety of species. Glycan is involved in innate immunity, cell regulatory pathways, protein interactions & folding, and cell shape modification. Glycobiology is a rapidly growing natural area with biotechnology, biomedicine, and research applications. After translation, most proteins in eukaryotic cells are changed. Glycan attachment is one of the most prevalent changes in living cells.

N-linked glycosylation, non-enzymatic glycosylated glycoproteins, and O-linked glycosylation are the three types of glycosylation. N-linked glycoproteins are involved in various biological activities, including cell-to-cell recognition, progression, differentiation, and apoptosis induction. The attachment of a sugar moiety to the oxygen atom of a protein's serine or threonine by-products is known as O-linked glycosylation.

Non-enzymatic glycosylation is the harsh chemical attachment of glucose to proteins that occurs when enzymes are not present. Glycobiology has several uses, including diagnostics, cancer, drug creation & development, immunology, and many more. Glycomics is a rapidly growing scientific discipline that focuses on identifying the key characteristics of glycan in biosystems.

Covid-19 Impact:

Pharmaceutical and biotech businesses, in collaboration with governments throughout the world, are striving to solve the COVID-19 epidemic, from vaccine research to planning for pharmaceutical supply chain issues. Approximately 115 vaccine candidates and 155 compounds are now in the R&D pipeline. Furthermore, routinely used medications such as hydroxychloroquine have seen a huge increase in demand for COVID-19 control. Because many wealthy nations are running out of these medications, the rising demand has created enormous potential for developers of COVID-19 management therapies. The pharmaceutical and biotechnology industries are predicted to increase significantly because of the need for COVID-19 vaccines and treatment medications.

Key Insights

  • As per the analysis shared by our research analyst, the global glycobiology/glycomics market value is expected to grow at a CAGR of 14.40% over the forecast period.
  • In terms of revenue, the global glycobiology/glycomics market size was valued at around USD 962.40 million in 2021 and is projected to reach USD 2157.30 million by 2028.
  • Developing pharmaceutical and biopharmaceutical firms The primary reasons driving the glycomics/glycobiology market are technological investments and economic development. The global glycomics/glycobiology market study offers a comprehensive market analysis.
  • By product, the instrument category dominated the market in 2021.
  • By application, the drug discovery and development category dominated the market in 2021.
  • North America dominated the global glycobiology/glycomics market in 2021.

Glycobiology/Glycomics Market: Growth Drivers

Developing pharmaceutical and biopharmaceutical firm drives the market.

Technological investments and economic development are the primary reasons driving the global glycomics/glycobiology market. Other enterprises in the sector can benefit from developing countries' strategic advantages. Technological developments are supporting growth due to several government R&D initiatives and drug discovery by biotechnology and pharmaceutical corporations. Furthermore, participation in glycomics and proteomics research projects is rising, which is expected to boost market development throughout the forecast period. Increased sales of medicines used to treat some severe chronic conditions are also expected to stimulate glycomics/glycobiology growth.

Glycobiology/Glycomics Market: Restraints

Higher costs of maintenance and regulation hamper the market growth.

These procedures necessitate the acquisition of necessary components. Regulation and maintenance of these devices are also costly, which may limit the global glycomics/glycobiology market growth throughout the projection period. Bacterial glycomics research has created a novel medicine, glycoconjugate vaccines, and physiologically active glycan. The intrinsic intricacy of glycosylation, as well as its thorough structural examination, is a difficult subject. Technological advancements in glycomics technologies have enabled researchers to understand the importance of glycan in biology, and this trend is expected to continue during the forecast period.

Glycobiology/Glycomics Market: Segmentation

The global glycomics/glycobiology market is segregated based on products, applications, end-user, and regions.

Based on product, the market is segmented into enzymes, instruments, carbohydrates, kits, reagents, and chemicals. Because of their widespread use in drug development and diagnostic testing, instruments commanded the biggest market share. Furthermore, repeated purchases of reagents and kits are projected to drive segment expansion. Because of advances in cancer therapies and detection, enzymes are expected to account for a sizable market share shortly. Glycomics employs a variety of research methods to quantify or characterize the glycomics of a tissue, cell, or organism. Changes in the location or activity of enzymes involved in glycan biosynthesis result in changes in the final glycan structure. As a result, in addition to genetic markers, glycans may be studied to detect environmental changes.

Based on application, the market is classified into disease diagnostics, drug discovery & development, and others. In 2021, drug discovery & development held the biggest market share. This is largely due to considerable R&D and increased government financing for glycomics and proteome research. Other applications are expected to grow faster throughout the projected period, owing to increased clinical trials and R&D costs invested by significant firms for research.

Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, and academic research institutes. Academic research institutes accounted for the greatest revenue share in 2021 due to increasing R&D spending. Collaborations between large corporations and research institutes are also helping to expand the industry. Due to increased R&D spending in drug discovery and development and other glycobiology-based studies, the pharmaceutical and biotechnology sector is expected to grow at the fastest CAGR during the projection period.

Glycobiology/Glycomics Market: Regional Landscape

North America dominates the glycobiology/glycomics market.

North America is predicted to be the fastest growing region in the global glycomics/glycobiology market throughout the forecast period. Increased investments in glycomics research, expanded pharmaceutical R&D investment potential for medicine development, and the presence of all main market rivals. North America is expected to dominate the worldwide glycomics market, followed by Europe. Most of North America's share is accounted for by the presence of all important firms, growing funding for glycomics research, expanding R&D spending for pharmaceutical discovery & development, and the presence of all key players. Because of significant pharmaceutical and biopharmaceutical businesses such as Merck KGaA, Agilent Technologies, Danaher, and Thermo Fisher Scientific, North America accounted for the greatest market share in 2021. The regional market has been pushed by well-established healthcare infrastructure and access to innovative goods. Furthermore, government support for R&D activities is a major driver driving glycobiology market expansion in this area.

Due to untapped market prospects, Asia Pacific is predicted to be the second-fastest growing regional market throughout the projection period. The region's glycomics industry has grown dramatically as a result of the region's developing pharmaceutical and biopharmaceutical sectors. Furthermore, Contract Research Organizations (CROs) investments in drug discovery and biologics manufacturing are likely to drive growth in the Asia Pacific glycomics market.

Glycobiology/Glycomics Market: Competitive Landscape

Some of the main competitors dominating the global glycobiology/glycomics market include Agilent Technologies, Waters Corporation, Lectenz Bio, Takara Bio, Thermo Fisher Scientific, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, and S Bio. 

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Glycobiology/glycomics Market is segmented as follows:

By Product

  • Enzymes
  • Instrument
  • Carbohydrates
  • Kits
  • Reagents and Chemicals
  • Others

By Application

  • Disease Diagnostics
  • Drug Discovery and Development
  • Others

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • Academic Research Institutes

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Glycobiology/Glycomics Market, (2022 - 2028) (USD Million)
    • 2.2 Global Glycobiology/Glycomics Market : snapshot
  • Chapter 3. Global Glycobiology/Glycomics Market - Industry Analysis
    • 3.1 Glycobiology/Glycomics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Developing pharmaceutical and biopharmaceutical firm drives the market
    • 3.3 Market Restraints
      • 3.3.1. Higher costs of maintenance and regulation hamper the market growth
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By Application
      • 3.7.3 Market attractiveness analysis By End-User
  • Chapter 4. Global Glycobiology/Glycomics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Glycobiology/Glycomics Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Glycobiology/Glycomics Market - Product Analysis
    • 5.1 Global Glycobiology/Glycomics Market overview: By Product
      • 5.1.1 Global Glycobiology/Glycomics Market share, By Product, 2021 and 2028
    • 5.2 Enzymes
      • 5.2.1 Global Glycobiology/Glycomics Market by Enzymes, 2022 - 2028 (USD Million)
    • 5.3 Instrument
      • 5.3.1 Global Glycobiology/Glycomics Market by Instrument, 2022 - 2028 (USD Million)
    • 5.4 Carbohydrates
      • 5.4.1 Global Glycobiology/Glycomics Market by Carbohydrates, 2022 - 2028 (USD Million)
    • 5.5 Kits
      • 5.5.1 Global Glycobiology/Glycomics Market by Kits, 2022 - 2028 (USD Million)
    • 5.6 Reagents and Chemicals
      • 5.6.1 Global Glycobiology/Glycomics Market by Reagents and Chemicals, 2022 - 2028 (USD Million)
    • 5.7 Others
      • 5.7.1 Global Glycobiology/Glycomics Market by Others, 2022 - 2028 (USD Million)
  • Chapter 6. Global Glycobiology/Glycomics Market - Application Analysis
    • 6.1 Global Glycobiology/Glycomics Market overview: By Application
      • 6.1.1 Global Glycobiology/Glycomics Market share, By Application, 2021 and 2028
    • 6.2 Disease Diagnostics
      • 6.2.1 Global Glycobiology/Glycomics Market by Disease Diagnostics, 2022 - 2028 (USD Million)
    • 6.3 Drug Discovery and Development
      • 6.3.1 Global Glycobiology/Glycomics Market by Drug Discovery and Development, 2022 - 2028 (USD Million)
    • 6.4 Others
      • 6.4.1 Global Glycobiology/Glycomics Market by Others, 2022 - 2028 (USD Million)
  • Chapter 7. Global Glycobiology/Glycomics Market - End-User Analysis
    • 7.1 Global Glycobiology/Glycomics Market overview: By End-User
      • 7.1.1 Global Glycobiology/Glycomics Market share, By End-User, 2021 and 2028
    • 7.2 Pharmaceutical and Biotechnology Companies
      • 7.2.1 Global Glycobiology/Glycomics Market by Pharmaceutical and Biotechnology Companies, 2022 - 2028 (USD Million)
    • 7.3 Clinical Laboratories
      • 7.3.1 Global Glycobiology/Glycomics Market by Clinical Laboratories, 2022 - 2028 (USD Million)
    • 7.4 Academic Research Institutes
      • 7.4.1 Global Glycobiology/Glycomics Market by Academic Research Institutes, 2022 - 2028 (USD Million)
  • Chapter 8. Glycobiology/Glycomics Market - Regional Analysis
    • 8.1 Global Glycobiology/Glycomics Market Regional Overview
    • 8.2 Global Glycobiology/Glycomics Market Share, by Region, 2021 & 2028 (USD Million)
    • 8.3. North America
      • 8.3.1 North America Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
        • 8.3.1.1 North America Glycobiology/Glycomics Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 North America Glycobiology/Glycomics Market, by Product, 2022 - 2028
      • 8.4.1 North America Glycobiology/Glycomics Market, by Product, 2022 - 2028 (USD Million)
    • 8.5 North America Glycobiology/Glycomics Market, by Application, 2022 - 2028
      • 8.5.1 North America Glycobiology/Glycomics Market, by Application, 2022 - 2028 (USD Million)
    • 8.6 North America Glycobiology/Glycomics Market, by End-User, 2022 - 2028
      • 8.6.1 North America Glycobiology/Glycomics Market, by End-User, 2022 - 2028 (USD Million)
    • 8.4. Europe
      • 8.4.2 Europe Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
        • 8.4.2.1 Europe Glycobiology/Glycomics Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Europe Glycobiology/Glycomics Market, by Product, 2022 - 2028
      • 8.4.1 Europe Glycobiology/Glycomics Market, by Product, 2022 - 2028 (USD Million)
    • 8.5 Europe Glycobiology/Glycomics Market, by Application, 2022 - 2028
      • 8.5.1 Europe Glycobiology/Glycomics Market, by Application, 2022 - 2028 (USD Million)
    • 8.6 Europe Glycobiology/Glycomics Market, by End-User, 2022 - 2028
      • 8.6.1 Europe Glycobiology/Glycomics Market, by End-User, 2022 - 2028 (USD Million)
    • 8.5. Asia Pacific
      • 8.5.3 Asia Pacific Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
        • 8.5.3.1 Asia Pacific Glycobiology/Glycomics Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Asia Pacific Glycobiology/Glycomics Market, by Product, 2022 - 2028
      • 8.4.1 Asia Pacific Glycobiology/Glycomics Market, by Product, 2022 - 2028 (USD Million)
    • 8.5 Asia Pacific Glycobiology/Glycomics Market, by Application, 2022 - 2028
      • 8.5.1 Asia Pacific Glycobiology/Glycomics Market, by Application, 2022 - 2028 (USD Million)
    • 8.6 Asia Pacific Glycobiology/Glycomics Market, by End-User, 2022 - 2028
      • 8.6.1 Asia Pacific Glycobiology/Glycomics Market, by End-User, 2022 - 2028 (USD Million)
    • 8.6. Latin America
      • 8.6.4 Latin America Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
        • 8.6.4.1 Latin America Glycobiology/Glycomics Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Latin America Glycobiology/Glycomics Market, by Product, 2022 - 2028
      • 8.4.1 Latin America Glycobiology/Glycomics Market, by Product, 2022 - 2028 (USD Million)
    • 8.5 Latin America Glycobiology/Glycomics Market, by Application, 2022 - 2028
      • 8.5.1 Latin America Glycobiology/Glycomics Market, by Application, 2022 - 2028 (USD Million)
    • 8.6 Latin America Glycobiology/Glycomics Market, by End-User, 2022 - 2028
      • 8.6.1 Latin America Glycobiology/Glycomics Market, by End-User, 2022 - 2028 (USD Million)
    • 8.7. The Middle-East and Africa
      • 8.7.5 The Middle-East and Africa Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
        • 8.7.5.1 The Middle-East and Africa Glycobiology/Glycomics Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 The Middle-East and Africa Glycobiology/Glycomics Market, by Product, 2022 - 2028
      • 8.4.1 The Middle-East and Africa Glycobiology/Glycomics Market, by Product, 2022 - 2028 (USD Million)
    • 8.5 The Middle-East and Africa Glycobiology/Glycomics Market, by Application, 2022 - 2028
      • 8.5.1 The Middle-East and Africa Glycobiology/Glycomics Market, by Application, 2022 - 2028 (USD Million)
    • 8.6 The Middle-East and Africa Glycobiology/Glycomics Market, by End-User, 2022 - 2028
      • 8.6.1 The Middle-East and Africa Glycobiology/Glycomics Market, by End-User, 2022 - 2028 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1 Agilent Technologies
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 Waters Corporation
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Lectenz Bio
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Takara Bio
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Thermo Fisher Scientific
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 Merck KGaA
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 New England Biolabs
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 ProZyme
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Shimadzu Corporation
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 S Bio.
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Glycobiology/Glycomics Market attractiveness, By Product
  • 6. Global Glycobiology/Glycomics Market attractiveness, By Application
  • 7. Global Glycobiology/Glycomics Market attractiveness, By End-User
  • 8. Global Glycobiology/Glycomics Market share by Product, 2022 and 2028 (USD Million)
  • 9. Global Glycobiology/Glycomics Market by Enzymes, 2022 - 2028 (USD Million)
  • 10. Global Glycobiology/Glycomics Market by Instrument, 2022 - 2028 (USD Million)
  • 11. Global Glycobiology/Glycomics Market by Carbohydrates, 2022 - 2028 (USD Million)
  • 12. Global Glycobiology/Glycomics Market by Kits, 2022 - 2028 (USD Million)
  • 13. Global Glycobiology/Glycomics Market by Reagents and Chemicals, 2022 - 2028 (USD Million)
  • 14. Global Glycobiology/Glycomics Market by Others, 2022 - 2028 (USD Million)
  • 15. Global Glycobiology/Glycomics Market share by Application, 2022 and 2028 (USD Million)
  • 16. Global Glycobiology/Glycomics Market by Disease Diagnostics, 2022 - 2028 (USD Million)
  • 17. Global Glycobiology/Glycomics Market by Drug Discovery and Development, 2022 - 2028 (USD Million)
  • 18. Global Glycobiology/Glycomics Market by Others, 2022 - 2028 (USD Million)
  • 19. Global Glycobiology/Glycomics Market share by End-User, 2022 and 2028 (USD Million)
  • 20. Global Glycobiology/Glycomics Market by Pharmaceutical and Biotechnology Companies, 2022 - 2028 (USD Million)
  • 21. Global Glycobiology/Glycomics Market by Clinical Laboratories, 2022 - 2028 (USD Million)
  • 22. Global Glycobiology/Glycomics Market by Academic Research Institutes, 2022 - 2028 (USD Million)
  • 23. Global Glycobiology/Glycomics Market share, by Region, 2022 and 2028
  • 24. North America Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
  • 25. Europe Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
  • 26. Asia Pacific Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
  • 27. Latin America Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)
  • 28. The Middle-East and Africa Glycobiology/Glycomics Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Glycobiology/Glycomics Market: Snapshot
  • 2. Drivers of the Glycobiology/Glycomics Market: impact analysis
  • 3. North America Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 4. North America Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 5. North America Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 6. U.S. Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 7. U.S. Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 8. U.S. Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 9. Canada Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 10. Canada Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 11. Canada Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 12. Europe Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 13. Europe Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 14. Europe Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 15. Germany Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 16. Germany Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 17. Germany Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 18. France Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 19. France Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 20. France Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 21. U.K. Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 22. U.K. Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 23. U.K. Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 24. Italy Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 25. Italy Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 26. Italy Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 27. Spain Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 28. Spain Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 29. Spain Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 30. Rest of Europe Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 31. Rest of Europe Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 32. Rest of Europe Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 33. Asia Pacific Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 34. Asia Pacific Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 35. Asia Pacific Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 36. China Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 37. China Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 38. China Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 39. Japan Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 40. Japan Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 41. Japan Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 42. India Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 43. India Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 44. India Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 45. South Korea Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 46. South Korea Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 47. South Korea Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 48. South-East Asia Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 49. South-East Asia Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 50. South-East Asia Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 51. Rest of Asia Pacific Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 52. Rest of Asia Pacific Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 53. Rest of Asia Pacific Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 54. Latin America Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 55. Latin America Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 56. Latin America Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 57. Brazil Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 58. Brazil Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 59. Brazil Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 60. Mexico Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 61. Mexico Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 62. Mexico Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 63. Rest of Latin America Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 64. Rest of Latin America Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 65. Rest of Latin America Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 66. The Middle-East and Africa Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 67. The Middle-East and Africa Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 68. The Middle-East and Africa Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 69. GCC Countries Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 70. GCC Countries Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 71. GCC Countries Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 72. South Africa Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 73. South Africa Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 74. South Africa Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 75. Rest of Middle-East Africa Glycobiology/Glycomics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 76. Rest of Middle-East Africa Glycobiology/Glycomics Market revenue, By Application, 2022 - 2028 (USD Million)
  • 77. Rest of Middle-East Africa Glycobiology/Glycomics Market revenue, By End-User, 2022 - 2028 (USD Million)

Methodology

Choose License Type

FrequentlyAsked Questions

The main reasons anticipated to propel the glycobiology/glycomics market during the forecast period are Developing pharmaceutical and biopharmaceutical firm The primary reasons driving the Glycomics/Glycobiology Market are technological investments and economic development.

According to the report, the global glycobiology/glycomics market size was worth USD 962.40 million in 2021 and is estimated to grow to USD 2157.30 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.40 percent over the forecast period.

The global market is predicted to be dominated by North America, followed by Europe. The greatest proportion of North America is mostly due to increased glycomics research spending, rising R&D investments in pharmaceutical businesses for medication discovery, and the presence of all significant competitors.

Some of the main competitors dominating the global glycobiology/glycomics market include - Agilent Technologies, Waters Corporation, Lectenz Bio, Takara Bio, Thermo Fisher Scientific, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, and S Bio. 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed